Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12-6.11 (-2.22%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $676.78B.
ENTERPRISE VALUE (EV)
$676.78B
Johnson & Johnson
Market Cap
$648.55B
Enterprise Value (EV)
$676.78B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Johnson & Johnson (JNJ) | $648.55B | $676.78B |
| Pfizer Inc. (PFE)vs › | $158.39B | $220.61B |
| Merck & Co., Inc. (MRK)vs › | $366.74B | $413.80B |
| AbbVie Inc. (ABBV)vs › | $439.68B | $503.94B |
| Eli Lilly and Company (LLY)vs › | $1.06T | $1.10T |
| Bristol-Myers Squibb Company (BMY)vs › | $132.14B | $166.54B |
Market Cap
$648.55B
Total Debt
$47.93B
Cash
$19.71B
Enterprise Value
$676.78B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute